Vol 27, No 4 (2020)
Editorial
Published online: 2020-09-10

open access

Page views 913
Article views/downloads 709
Get Citation

Connect on Social Media

Connect on Social Media

ISCHEMIA trial: Back to the future or forward to the past?

Ana Pardo Sanz, Pedro Marcos Alberca, José Luis Zamorano
Pubmed: 32929702
Cardiol J 2020;27(4):342-344.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Maron D, Hochman J, Reynolds H, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020; 382(15): 1395–1407.
  2. Hochman JS, Reynolds HR, Bangalore S, et al. Baseline characteristics and risk profiles of participants in the ISCHEMIA randomized clinical trial. JAMA Cardiol. 2019; 4(3): 273–286.
  3. Newby DE, Adamson PD, Berry C, et al. SCOT-HEART Investigators. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018; 379(10): 924–933.
  4. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
  5. Gutiérrez-Chico JL, Louvard Y. DECISION-CTO: A "negative" clinical trial? Really? Cardiol J. 2017; 24(3): 231–233.
  6. Lee HS, Lee JM, Nam CW, et al. Consensus document for invasive coronary physiologic assessment in Asia-Pacific countries. Cardiol J. 2019; 26(3): 215–225.
  7. Gutiérrez-Chico JL, Chen Y, Yu W, et al. Diagnostic accuracy and reproducibility of optical flow ratio for functional evaluation of coronary stenosis in a prospective series. Cardiol J. 2020 [Epub ahead of print].